Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Uridine_Diphosphate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY2 known ✓ | P41231 | 13/20 | 0.88 |
| ▸ | P2RY6 known ✓ | Q15077 | 9/20 | 0.88 |
| ▸ | P2RY4 known ✓ | P51582 | 7/20 | 0.88 |
| ▸ | P2RY14 | Q15391 | 6/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Uridine Triphosphate SCHEMBL29764233 | 0.98 | P2RY2 (0.92) | P2RY2P2RY6P2RY4P2RY14 | |
| Uridine Triphosphate SCHEMBL1230651 | 0.98 | P2RY2 (0.92) | P2RY2P2RY6P2RY4P2RY14 | |
| SCHEMBL4149994 | 0.98 | P2RY2 (0.92) | P2RY2P2RY6P2RY4P2RY14 | |
| Uridine Triphosphate SCHEMBL27196289 | 0.97 | P2RY2 (0.90) | P2RY2P2RY6P2RY4P2RY14 | |
| Uridine Triphosphate SCHEMBL317396 | 0.97 | P2RY2 (0.90) | P2RY2P2RY6P2RY4P2RY14 | |
| Uridine_Diphosphate SCHEMBL1321688 | 0.94 | P2RY2 (0.92) | P2RY2P2RY6P2RY4P2RY14 | |
| Diquafosol SCHEMBL1651092 | 0.94 | P2RY2 (1.00) | P2RY2P2RY6P2RY4P2RY14 | |
| Uridine_Diphosphate SCHEMBL23534623 | 0.93 | P2RY2 (0.90) | P2RY2P2RY6P2RY4P2RY14 | |
| Uridine_Diphosphate SCHEMBL31501785 | 0.93 | P2RY2 (0.90) | P2RY2P2RY6P2RY4P2RY14 | |
| SCHEMBL28484030 | 0.92 | P2RY2 (0.82) | P2RY2P2RY6P2RY4P2RY14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120060187-A | Immobilized enzyme composition and application thereof in efficient preparation of rebaudioside M | 成都圆大生物科技有限公司 | 2025-05-30 | — | — | CN | claimed |
| CN-120005924-A | Method for synthesizing rebaudioside M by utilizing enzyme cascade reaction | 江苏大学 | 2025-05-16 | — | — | CN | claimed |
| CN-118207275-A | Method for producing rebaudioside D and D-psicose by one-pot method | 万华化学集团股份有限公司 | 2024-06-18 | — | — | CN | claimed |
| CN-118165949-A | Co-immobilized enzyme and preparation method and application thereof | 万华化学集团股份有限公司 | 2024-06-11 | — | — | CN | claimed |
| CN-118147258-A | Method for recycling disodium uridine diphosphate and application thereof | 万华化学集团股份有限公司 | 2024-06-07 | — | — | CN | claimed |
| CN-116478228-A | Uridine diphosphate metal complex, preparation method and application thereof | 北京理工大学 | 2023-07-25 | — | — | CN | claimed |
| CN-219231473-U | Crystallization equipment of disodium uridine diphosphate | 江苏香地化学有限公司 | 2023-06-23 | — | — | CN | claimed |
| CN-114836398-B | Application of glycosyltransferase mutant in directional synthesis of non-natural ginsenoside | 南京工业大学 | 2023-06-23 | — | — | CN | claimed |
| CN-116144623-A | Glycosyltransferase mutant and application thereof in preparing rare ginsenoside by enzymatic method | 南京工业大学 | 2023-05-23 | — | — | CN | claimed |
| CN-111662350-B | Preparation method of green intelligent high-purity diquafosol tetrasodium | 南京宸翔医药研究有限责任公司 | 2022-06-07 | — | — | CN | claimed |
| CN-109021049-B | Synthesis method of uridine 5' -diphosphate-benzimidazole disodium | 扬子江药业集团北京海燕药业有限公司 | 2020-12-08 | — | — | CN | claimed |
| CN-211585283-U | Disodium uridine diphosphate crystallization kettle | 美亚药业海安有限公司 | 2020-09-29 | — | — | CN | claimed |
| CN-111662350-A | Preparation method of green intelligent high-purity diquafosol tetrasodium | 南京宸翔医药研究有限责任公司 | 2020-09-15 | — | — | CN | claimed |
| CN-108739195-B | Efficient improved peanut seed breeding method | 吉林省农业科学院 | 2020-08-07 | — | — | CN | claimed |
| CN-108739195-A | A kind of efficient peanut stock breeding method | 吉林省农业科学院 | 2018-11-06 | — | — | CN | claimed |
| US-12533371-B2 | Multilayer pharmaceutical or nutraceutical solid dosage forms comprising pyrimidine and/or purine derivatives and b vitamins, preparation and uses thereof | FERRER INTERNACIONAL, S.A. (ES) | 2026-01-27 | — | — | US | disclosed |
| EP-4667479-A1 | POLYPHOSPHORYLATED NUCLEOSIDE, PHOSPHATE-ACTIVATED NUCLEOTIDE USED FOR SYNTHESIS OF POLYPHOSPHORYLATED NUCLEOSIDE AND METHOD FOR SYNTHESIS OF SAME, AND METHOD FOR SYNTHESIS OF POLYPHOSPHORYLATED NUCLEOSIDE USING PHOSPHATE-ACTIVATED NUCLEOTIDE | Natias Inc. (JP) | 2025-12-24 | — | — | EP | disclosed |
| EP-1012154-A2 | SALTS OF DI(URIDINE 5'-TETRAPHOSPHATE), METHOD FOR PREPARATION AND USES THEREOF | Inspire Pharmaceuticals, Inc. (US) | 2000-06-28 | — | — | EP | disclosed |
| WO-1999005155-A2 | SALTS OF DI(URIDINE 5'-TETRAPHOSPHATE), METHOD FOR PREPARATION AND USES THEREOF | INSPIRE PHARMACEUTICALS, INC. (US) | 1999-02-04 | — | — | WO | disclosed |
| US-4058601-A | URIDINE DIPHOSPHATE | CHUGAI SEIYAKU KABUSHIKI KAISHA (JA) | 1977-11-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12533371-B2 | Multilayer pharmaceutical or nutraceutical solid dosage forms comprising pyrimidine and/or purine derivatives and b vitamins, preparation and uses thereof | P2RY10, TYMP, P2RY12 | P2RY2 42/4885P2RY6 17/4885P2RY4 37/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.